Amylyx Pharmaceuticals, Inc. (AMLX) Gross profit 2022–2025
Amylyx Pharmaceuticals, Inc. (AMLX) annual gross profit history from SEC filings — each fiscal year as reported.
$0FY2025 · since FY2022: $19.2M → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $81.4M | -77.1% |
| FY2023 | $355.3M | +1747.2% |
| FY2022 | $19.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice